Illumina Inc. (ILMN)
NASDAQ: ILMN
· Real-Time Price · USD
100.62
5.65 (5.95%)
At close: Oct 01, 2025, 1:50 PM
5.95% (1D)
| Bid | 100.56 |
| Market Cap | 15.47B |
| Revenue (ttm) | 4.28B |
| Net Income (ttm) | 1.26B |
| EPS (ttm) | 7.92 |
| PE Ratio (ttm) | 12.7 |
| Forward PE | 19.06 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 100.7 |
| Volume | 1,071,926 |
| Avg. Volume (20D) | 1,832,720 |
| Open | 94.97 |
| Previous Close | 94.97 |
| Day's Range | 94.97 - 101.94 |
| 52-Week Range | 68.70 - 156.66 |
| Beta | 1.43 |
| Ex-Dividend Date | n/a |
About ILMN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ILMN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ILMN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsIllumina Inc. is scheduled to release its earnings on
Nov 3, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 hours ago
Illumina shares are trading higher. The company an...
Unlock content with
Pro Subscription
6 days ago
-2.35%
Shares of medical technology stocks are trading lower after the US opened national security investigations into imports of medical equipment, industrial machinery and robotics.
1 month ago · prismmediawire.com
BioStem Technologies Appoints Brandon Poe as Chief Financial OfficerSeasoned healthcare CFO with senior experience in capital markets and financial operations across private and publicly traded companies to lead BioStem's financial team POMPANO BEACH, FL, August 14, 2...
